BridgeBio is a Venture Capital firm based in San Francisco, United States.

Publicly traded biotechnology company developing medicines for genetic diseases; invests in pipeline subsidiaries.

Growth
Late Stage
Biotech
Genetic Medicine
Healthcare
Headquarters
San Francisco, United States
Founded
2015
Portfolio Company
1
Total Investments
3
Last Investment
Jan 2021
Geographic Focus
United States
Use investor data through the API.
Example request
curl "https://indexed.vc/api/v1/investors/bridgebio?depth=slim" -H "X-API-Key: YOUR_API_KEY"

Indexed holds 1 portfolio company and 3 funding rounds for this investor. The full record is or through the API.

Investment Thesis

Build and fund genetically-validated drug programs using portfolio theory to diversify pipeline risk across rare genetic diseases.

It was founded in 2015. It has made 3 investments. Its portfolio includes Eidos Therapeutics. Focus areas include Biotech and Genetic Medicine.

Portfolio1

Co-investors6

Sign up to view co-investors

6 co-investors across 6 shared portfolio companies — who they back alongside, and how often they lead.

Hedge Fund ×2 · Venture Capital ×2 · Private Equity ×1 · 5 shared rounds

Investment History

Data from Indexed.vcUpdated

Sign up to view investment history

Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.

Your firm? Embed this profile

Add the live badge to your site — it stays current as your portfolio data updates.

BridgeBio on Indexed.vc
<a href="https://indexed.vc/investors/bridgebio"><img src="https://indexed.vc/api/badge/investor/bridgebio" alt="BridgeBio on Indexed.vc" width="260" height="76" /></a>